1. From HDAC to Voltage-Gated Ion Channels: What’s Next? The Long Road of Antiepileptic Drugs Repositioning in Cancer
   Michele Pellegrino et al, 2022, Cancers CrossRef
2. Anti‐tumor effects of suberoylanilide hydroxamic acid on Epstein–Barr virus‐associated T cell and natural killer cell lymphoma
   Mohammed N.A. Siddiquey et al, 2014, Cancer Science CrossRef
3. HDAC Inhibition Counteracts Metastatic Re-Activation of Prostate Cancer Cells Induced by Chronic mTOR Suppression
   Jasmina Makarević et al, 2018, Cells CrossRef
4. Clinicopathological signature of p21-activated kinase 1 in prostate cancer and its regulation of proliferation and autophagy via the mTOR signaling pathway
   Zhanyu Wang et al, 2017, Oncotarget CrossRef
5. mTOR Inhibitors Induce Cell-Cycle Arrest and Inhibit Tumor Growth in Epstein–Barr Virus–Associated T and Natural Killer Cell Lymphoma Cells
   Jun-ichi Kawada et al, 2014, Clinical Cancer Research CrossRef
6. Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives
   Robert Jenke et al, 2021, Cancers CrossRef